A Case of Severe COVID-19 in a Patient with Good's Syndrome

Keywords

COVID-19, Good’s syndrome, immunoglobulin

Abstract

Good’s syndrome is a rare adult-onset combined immunodeficiency. The association of hypogammaglobulinaemia with a history of recurrent infectious or autoimmune manifestations in a middle-aged patient with evidence of a mediastinal mass should lead to the clinical suspicion of Good’s syndrome. The mortality rate associated with infectious complications is high. Thus, although it is rare, the disease should be diagnosed early so that proper treatment can be started. Thymectomy and immunoglobulin replacement are the main therapeutic strategies. We describe the case of a patient with a history of thymoma and recurrent respiratory infections, with a late diagnosis of Good’s syndrome in the context of severe organizing pneumonia secondary to COVID-19.

VIEW THE ENTIRE ARTICLE

References

  • Shi Y, Wang C. When the Good syndrome goes bad: a systematic literature review. Front Immunol 2021;12:679556. doi: 10.3389/fimmu.2021.679556.
  • Guevara-Hoyer K, Fuentes-Antrás J, Calatayud Gastardi J, Sánchez-Ramón S. Immunodeficiency and thymoma in Good syndrome: two sides of the same coin. Immunol Lett 2021;231:11–17. doi: 10.1016/j.imlet.2020.12.010.
  • Tamburello A, Castelnovo L, Faggioli P, Bompane D, Brando B, Gatti A, et al. Good's syndrome, a rare form of acquired immunodeficiency associated with thymomas. Clin Pract 2019;9(2):1112. doi: 10.4081/cp.2019.1112.
  • Jansen A, van Deuren M, Miller J, Litzman J, de Gracia J, Sáenz-Cuesta M, et al; Good syndrome Study Group. Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective. Clin Immunol 2016;171:12–17. doi: 10.1016/j.clim.2016.07.025.
  • Pu C, Sukhal S, Fakhran S. Humoral immunity in bronchiectasis: finding Good's syndrome. Case Rep Pulmonol 2015;2015:531731. doi: 10.1155/2015/531731.
  • London J, Boutboul D, Lacombe K, Pirenne F, Heym B, Zeller V, et al. Severe COVID-19 in patients with B cell alymphocytosis and response to convalescent plasma therapy. J Clin Immunol 2021;41(2):356–361. doi: 10.1007/s10875-020-00904-5.
  • López AL, Torre MG, Paolini MV, Juri MC, Fernández Romero DS. COVID-19 in adults with antibody deficiencies. Medicina (B Aires) 2021;81(3):478–481.
  • Cos Esquius ML, López Montesinos I, Gimeno Martinez R, Eguía Núñez J, Caballero-Rabasco MA, Sánchez González B, et al. Severe COVID-19 pneumonia in Good syndrome with a favorable outcome. Clin Immunol 2021 Jun 29:108789. doi: 10.1016/j.clim.2021.108789.
  • Published: 2021-10-29

    Issue: 2021: Vol 8 No 10 (view)

    Section: Articles

    How to cite:
    1.
    Duarte M, Faria L, Patronillo C, da Costa Fernandes S, Seara V. A Case of Severe COVID-19 in a Patient with Good’s Syndrome. EJCRIM 2021;8 doi:10.12890/2021_002976.